CardioNet Announces that Highmark Medicare Services Posts Reimbursement Rate for CPT Code 93229, Mobile Cardiovascular Telemetry Services

CONSHOHOCKEN, Pa.--(Business Wire)--
CardioNet, Inc. (NASDAQ:BEAT) today announced that last week Highmark Medicare
Services posted a reimbursement rate for CPT code 93229, Mobile Cardiovascular
Telemetry Services, of $1,123.07 at:
www.highmarkmedicareservices.com/partb/reimbursement/calc-2009.html.

Highmark Medicare Services had not posted a reimbursement rate for CPT code
93229 since the CPT code was published by the AMA in October of 2008. The
reimbursement of $1,123.07 reflects the same rate that the Company announced in
November 2008 on attaining the CPT code.

About CardioNet, Inc.

CardioNet, Inc. is the leading provider of ambulatory, continuous, real-time
outpatient management solutions for monitoring relevant and timely clinical
information regarding an individual's health. CardioNet's initial efforts are
focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm
disorders, with a solution that it markets as Mobile Cardiac Outpatient
Telemetry (MCOT). More information can be found at http://www.cardionet.com.

Forward Looking Statements

This press release includes certain forward-looking statements regarding
CardioNet, Inc. within the meaning of the "Safe Harbor" provisions of the
Private Securities Litigation Reform Act of 1995 regarding, among other things,
the reimbursement rates for CardioNet, Inc. products and technology, which may
change in the future, and the actions of Highmark Medicare Services and the
Centers for Medicare and Medicaid Services (CMS), including actions related to
reimbursement rates for CardioNet, Inc. products and technology. These
statements may be identified by words such as "expect," "anticipate,"
"estimate," "intend," "plan," "believe," and other words and terms of similar
meaning. Such forward-looking statements are based on current expectations and
involve inherent risks and uncertainties, including important factors that could
delay, divert, or change any of them, and could cause actual outcomes and
results to differ materially from current expectations. These factors include,
among other things, the ability of Highmark Medicare Services and CMS to change
reimbursement rates for CardioNet, Inc. products and technology and the timing
of any such change, changes in governmental regulations and legislation, and
other changes to reimbursement levels for CardioNet`s products and technology.
For further details and a discussion of these and other risks and uncertainties,
please see CardioNet`s public filings with the Securities and Exchange
Commission, including CardioNet`s latest periodic report on Form 10-K or 10-Q.
CardioNet undertakes no obligation to publicly update any forward-looking
statement, whether as a result of new information, future events, or otherwise.

CardioNet, Inc.
Marty Galvan
Investor Relations
800-908-7103
investorrelations@cardionet.com

Copyright Business Wire 2009